These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6748559)

  • 1. [Pharmacokinetics and cardiac effect of beta-acetyldigoxin and digitoxin in combination therapy with nifedipine].
    Kuhlmann J; Marcin S; Frank KH
    Klin Wochenschr; 1984 May; 62(10):451-7. PubMed ID: 6748559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic and cardiac efficacy of beta-acetyldigoxin and digitoxin in combination therapy with diltiazem].
    Kuhlmann J; Marcin S
    Klin Wochenschr; 1985 Jul; 63(14):636-42. PubMed ID: 4032988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quinidine, verapamil and nifedipine on the pharmacokinetics and pharmacodynamics of digitoxin during steady state conditions.
    Kuhlmann J
    Arzneimittelforschung; 1987 May; 37(5):545-8. PubMed ID: 3619976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
    Kuhlmann J
    Clin Pharmacol Ther; 1985 Dec; 38(6):667-73. PubMed ID: 3905167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of verapamil on pharmacokinetics and pharmacodynamics of digitoxin in patients.
    Kuhlmann J; Marcin S
    Am Heart J; 1985 Dec; 110(6):1245-50. PubMed ID: 4072882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.
    Kuhlmann J
    Clin Pharmacol Ther; 1985 Feb; 37(2):150-6. PubMed ID: 3967458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic studies using alpha-acetyldigoxin. Results of radiocardiographic measures].
    Leb G; Klein W; Passath A; Pavek P; Eber O
    Z Kardiol; 1974 Mar; 63(3):211-9. PubMed ID: 4605696
    [No Abstract]   [Full Text] [Related]  

  • 8. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions.
    Kuhlmann J; Dohrmann M; Marcin S
    Clin Pharmacol Ther; 1986 Mar; 39(3):288-94. PubMed ID: 3512148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 11. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
    Haustein KO
    Eur J Clin Pharmacol; 1981 Jan; 19(1):45-51. PubMed ID: 7461023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis.
    Finkelstein FO; Goffinet JA; Hendler ED; Lindenbaum J
    Am J Med; 1975 Apr; 58(4):525-31. PubMed ID: 1124790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are non-kidney-dependent digitalis glycosides therapeutically safer?].
    Rietbrock N; Woodcock BG
    ZFA (Stuttgart); 1983 Aug; 59(24):1290-5. PubMed ID: 6636996
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal systolic time intervals in obesity and their relationship with the amount of overweight.
    Romano M; Carella G; Cotecchia MR; Di Maro T; Indolfi C; Ferro G; Chiariello M
    Am Heart J; 1986 Aug; 112(2):356-60. PubMed ID: 2943149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent shortening of systolic time intervals after intake of pengitoxin.
    Haustein KO; Hentschel H
    Int J Clin Pharmacol Res; 1987; 7(1):19-25. PubMed ID: 3583485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
    Storstein L; Bjørnstad H; Mølstad P
    Z Kardiol; 1985; 74 Suppl 2():34-6. PubMed ID: 4002802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of quinidine sulfate on QRS duration and QT and systolic time intervals in man.
    Fieldman A; Beebe RD; Sing Sum Chow M
    J Clin Pharmacol; 1977; 17(2-3):134-9. PubMed ID: 833343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems of an optimum digitalis therapy.
    Haustein KO; Hentschel H; Kaiser B
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):352-6. PubMed ID: 7409938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digitoxin blood picture and renal elimination in long-term therapy with aluminum-magnesium hydroxide gel].
    Kuhlmann J
    Dtsch Med Wochenschr; 1984 Jan; 109(2):59-61. PubMed ID: 6692764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic time intervals in chronic severe anaemia and effect of diuretic and digitalis.
    Warrier ER; Balakrishnan KG; Sankaran K; Gupta GD
    Br Heart J; 1981 Jul; 46(1):80-3. PubMed ID: 7272117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.